Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1U97
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,278
Award facts
- Contract value 100% obligated
- $50,277.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,277.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Dupixent 300 mg/2 ml pen injections with an ultimate completion date of January 15, 2026. This competitive award, which carries no set-aside designation, represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters and serves as a critical vendor for federal medical procurement.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that supplies a comprehensive range of medical products to military healthcare systems and other federal agencies. The Dupixent delivery supports the Defense Health Agency's medical supply needs and exemplifies the type of specialty pharmaceutical products distributed under the broader DLA Troop Support Medical contract vehicle, which encompasses brand-name medications, generics, vaccines, and specialized medical supplies across multiple therapeutic domains. AmerisourceBergen's ability to secure this award through open competition reflects its established capability to fulfill federal pharmaceutical procurement requirements efficiently and reliably.
Quick answers
Who was awarded contract SPE2DR26F1U97?
SPE2DR26F1U97 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F1U97 worth?
The government has obligated $50,278 on SPE2DR26F1U97.
Is contract SPE2DR26F1U97 an order under another contract?
Yes. SPE2DR26F1U97 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U97 competed?
The extent of competition for SPE2DR26F1U97 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award